Login Register Cart 0
Generic placeholder image

Current Rheumatology Reviews

Editor-in-Chief

ISSN (Print): 1573-3971
ISSN (Online): 1875-6360

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Is there an Association between Complementary and Alternative Medicine use and Trust in Physicians in Patients with Rheumatic Diseases?

Author(s): Fatima Zahra Aharrane*, Fatima Zahrae Taik, Nihad Takhrifa, Rajaa Bensaid, Nabil Soba, Maryam Fourtassi and Fatima Ezzahra Abourazzak

Volume 20, Issue 4, 2024

Published on: 10 January, 2024

Page: [444 - 450] Pages: 7

DOI: 10.2174/0115733971271511231220101117

Price: $65

Abstract

Introduction: Generally, patients with chronic rheumatic diseases use complementary and alternative medicine (CAM) in addition to their conventional treatments to manage their health. Discussing these treatments with their physician is still rare, which might be directly related to patients’ trust toward them.

Aim: The primary objective of this study was to assess the association between patients’ trust in their physician and the use of complementary and alternative medicine among patients with chronic inflammatory rheumatic diseases. As secondary objectives, to estimate the prevalence of CAM use, and to identify the associated factors with their use and with trust in physicians.

Methods: This is a cross-sectional study, which included patients with established chronic inflammatory rheumatic diseases, at the University Hospital Center in Tangier. The questionnaire included demographic and clinical information, use of conventional therapy, complementary and alternative therapy, as well as interpersonal trust in patient-physician relationships using the Trust in Physician Scale (TPS). A regression analysis was conducted to identify factors associated with CAM use and with trust in physicians.

Results: The study included 189 patients. 57.14% of patients reported using complementary medicine at least once, most patients were women (77.78%), mean age was 46.67 ± 13.25 years with an average course of the disease of 11.11 ± 9.23 years. The most frequently used CAM treatments were cupping therapy, massage and the ingestion of a mixture of plants. Mean ± SD Trust in Physician Scale was 47.64 ± 7.2. There was no significant difference between CAM users vs. non-users (48.08 ± 6.9 vs 47.04 ± 7.4; p = 0.35). In uni and multivariate analysis, a low level of education was significantly associated with the use of CAM. However, no statistically significant difference was found with trust in physicians (OR = 1.020, 95% CI (0.978-1.063), p = 0.354).

Conclusion: CAM therapy is common in patients with chronic inflammatory rheumatic diseases. No statistically significant association was found with trust in physicians, it was rather observed with level of education.

« Previous Next »
Graphical Abstract

[1]
Saydah SH, Eberhardt MS. Use of complementary and alternative medicine among adults with chronic diseases: United States 2002. J Altern Complement Med 2006; 12(8): 805-12.
[http://dx.doi.org/10.1089/acm.2006.12.805] [PMID: 17034287]
[2]
What Is Complementary and Alternative Medicine. 2002.
[3]
Zezos P, Nguyen GC. Use of complementary and alternative medicine in inflammatory bowel disease around the world. Gastroenterol Clin North Am 2017; 46(4): 679-88.
[http://dx.doi.org/10.1016/j.gtc.2017.08.001] [PMID: 29173516]
[4]
Bishop FL, Lewith GT. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. Evid Based Complement Alternat Med 2010; 7(1): 11-28.
[http://dx.doi.org/10.1093/ecam/nen023] [PMID: 18955327]
[5]
Roy V, Gupta M, Ghosh R. Perception, attitude and usage of complementary and alternative medicine among doctors and patients in a tertiary care hospital in India. Indian J Pharmacol 2015; 47(2): 137-42.
[http://dx.doi.org/10.4103/0253-7613.153418] [PMID: 25878370]
[6]
Mongiovi J, Shi Z, Greenlee H. Complementary and alternative medicine use and absenteeism among individuals with chronic disease. BMC Complement Altern Med 2016; 16(1): 248.
[http://dx.doi.org/10.1186/s12906-016-1195-9] [PMID: 27460643]
[7]
Ng JY, Azizudin AM. Rheumatoid arthritis and osteoarthritis clinical practice guidelines provide few complementary and alternative medicine therapy recommendations: A systematic review. Clin Rheumatol 2020; 39(10): 2861-73.
[http://dx.doi.org/10.1007/s10067-020-05054-y] [PMID: 32385761]
[8]
Gupta YK, Srivastava A, Sharma S, Kumar G, Rao TD. Efficacy & safety evaluation of Ayurvedic treatment (Ashwagandha powder & Sidh Makardhwaj) in rheumatoid arthritis patients: A pilot prospective study. Indian J Med Res 2015; 141(1): 100-6.
[http://dx.doi.org/10.4103/0971-5916.154510] [PMID: 25857501]
[9]
Fernández-Llanio Comella N, Fernández Matilla M, Castellano Cuesta JA. Have complementary therapies demonstrated effectiveness in rheumatoid arthritis? Reumatol Clin 2016; 12(3): 151-7.
[http://dx.doi.org/10.1016/j.reuma.2015.10.011] [PMID: 26711840]
[10]
Tahiri L, Boussaadani R, Bayi J, et al. Use of complementary medicine by rheumatoid arthritis patients. Rev Mar Rhum 2012; 22: 57-61.
[http://dx.doi.org/10.24398/A.83.2012]
[11]
Farrukh MJ, Makmor Bakry M, Hatah E, Jan TH. Use of complementary and alternative medicine and adherence to antiepileptic drug therapy among epilepsy patients: A systematic review. Patient Prefer Adherence 2018; 12: 2111-21.
[http://dx.doi.org/10.2147/PPA.S179031] [PMID: 30349205]
[12]
Lakatos PL, Czegledi Z, David G, et al. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. J Crohn’s Colitis 2010; 4(3): 283-90.
[http://dx.doi.org/10.1016/j.crohns.2009.11.011] [PMID: 21122517]
[13]
Freburger JK, Callahan LF, Currey SS, Anderson LA. Use of the trust in physician scale in patients with rheumatic disease: Psychometric properties and correlates of trust in the rheumatologist. Arthritis Care Res 2003; 49(1): 51-8.
[http://dx.doi.org/10.1002/art.10925] [PMID: 12579593]
[14]
Berrios-rivera JP, Street RL Jr, Garcia Popa-lisseanu MG, et al. Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res 2006; 55(3): 385-93.
[http://dx.doi.org/10.1002/art.21988] [PMID: 16739207]
[15]
Padilla-Ortiz D, Contreras-Yáñez I, Cáceres-Giles C, et al. Use of complementary and alternative medicine and its association with the doctor-patient relationship in patients with rheumatoid arthritis. Colomb J Rheumatol 2021; 28(1): 28-37.
[http://dx.doi.org/10.1016/j.rcreu.2020.06.008]
[16]
Arnett FC, Edworthy SM, Bloch DA, et al. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31(3): 315-24.
[http://dx.doi.org/10.1002/art.1780310302] [PMID: 3358796]
[17]
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: An american college of rheumatology/european league against rheumatism collaborative initiative. Arthritis Rheum 2010; 62(9): 2569-81.
[http://dx.doi.org/10.1002/art.27584] [PMID: 20872595]
[18]
Rudwaleit M, Landewé R, van der Heijde D, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): Classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009; 68(6): 770-6.
[http://dx.doi.org/10.1136/ard.2009.108217] [PMID: 19297345]
[19]
Dixon W, Symmons D. Does early rheumatoid arthritis exist? Best Pract Res Clin Rheumatol 2005; 19(1): 37-53.
[http://dx.doi.org/10.1016/j.berh.2004.08.003] [PMID: 15588970]
[20]
Anderson LA, Dedrick RF. Development of the Trust in Physician scale: A measure to assess interpersonal trust in patient-physician relationships. Psychol Rep 1990; 67(3_suppl): 1091-100.
[http://dx.doi.org/10.2466/pr0.1990.67.3f.1091] [PMID: 2084735]
[21]
Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: Development and validation. Psychol Assess 1995; 7(4): 524-32.
[http://dx.doi.org/10.1037/1040-3590.7.4.524]
[22]
AlHadi AN, AlAteeq DA, Al-Sharif E, et al. An arabic translation, reliability, and validation of Patient Health Questionnaire in a Saudi sample. Ann Gen Psychiatry 2017; 16(1): 32.
[http://dx.doi.org/10.1186/s12991-017-0155-1] [PMID: 28878812]
[23]
Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999; 14(1): 1-24.
[http://dx.doi.org/10.1080/08870449908407311]
[24]
Turk JL, Allen E. Bleeding and cupping. Ann R Coll Surg Engl 1983; 65(2): 128-31.
[PMID: 6338802]
[25]
Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney WM, Weinberger M. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 1999; 131(6): 409-16.
[http://dx.doi.org/10.7326/0003-4819-131-6-199909210-00003] [PMID: 10498556]
[26]
Almuhareb AM, Alhawassi TM, Alghamdi AA, et al. Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia. Saudi Pharm J 2019; 27(7): 939-44.
[http://dx.doi.org/10.1016/j.jsps.2019.07.002] [PMID: 31997900]
[27]
Lee MS, Lee MS, Yang CY, et al. Use of complementary and alternative medicine by rheumatoid arthritis patients in Korea. Clin Rheumatol 2008; 27(1): 29-33.
[http://dx.doi.org/10.1007/s10067-007-0646-6] [PMID: 17541497]
[28]
Chatfield SM, Dharmage SC, Boers A, et al. Complementary and alternative medicines in ankylosing spondylitis: A cross-sectional study. Clin Rheumatol 2009; 28(2): 213-7.
[http://dx.doi.org/10.1007/s10067-008-1029-3] [PMID: 18985421]
[29]
Alaaeddine N, Okais J, Ballane L, Baddoura RM. Use of complementary and alternative therapy among patients with rheumatoid arthritis and osteoarthritis. J Clin Nurs 2012; 21(21-22): 3198-204.
[http://dx.doi.org/10.1111/j.1365-2702.2012.04169.x] [PMID: 22776021]
[30]
Kajiyama H, Akama H, Yamanaka H, et al. One third of Japanese patients with rheumatoid arthritis use complementary and alternative medicine. Mod Rheumatol 2006; 16(6): 355-9.
[http://dx.doi.org/10.3109/s10165-006-0521-3] [PMID: 17164996]
[31]
Alsharif F. Discovering the use of complementary and alternative medicine in oncology patients: A systemic literature review. Evi Complemen Altern Med. 2021.
[http://dx.doi.org/10.1155/2021/6619243]
[32]
Gözcü E, Çakmak İ, Öz B, Karataş A, Akar ZA, Koca SS. Complementary alternative medicine in rheumatic diseases: Causes, choices, and outcomes according to patients. Eur J Rheumatol 2022; 9(1): 36-41.
[http://dx.doi.org/10.5152/eurjrheum.2021.20194] [PMID: 35110135]
[33]
Obalum DC, Ogo CN. Usage of complementary and alternative medicine (CAM) among osteoarthritis patients attending an urban multi-specialist hospital in Lagos, Nigeria. Niger Postgrad Med J 2011; 18(1): 44-7.
[http://dx.doi.org/10.4103/1117-1936.170303] [PMID: 21445112]
[34]
Han M, Sung YK, Cho SK, et al. Factors associated with the use of complementary and alternative medicine for korean patients with rheumatoid arthritis. J Rheumatol 2015; 42(11): 2075-81.
[http://dx.doi.org/10.3899/jrheum.141447] [PMID: 26329343]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy